Jay A. Fishman Ltd’s Gilead Sciences GILD Stock Holding History

Jay A. Fishman Ltd’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-167,645	Closed	-$17M	–	92
2015 Q4	$17M	Sell	167,645 -3,075	-2%	-$320K	4.13%	7
2015 Q3	$16.8M	Sell	170,720 -625	-0.4%	-$69.4K	4.02%	6
2015 Q2	$20.1M	Sell	171,345 -2,800	-2%	-$306K	4.17%	6
2015 Q1	$17.1M	Buy	174,145 +5,345	+3%	+$543K	3.58%	8
2014 Q4	$15.9M	Buy	168,800 +3,625	+2%	+$375K	3.48%	9
2014 Q3	$17.6M	Buy	165,175 +9,245	+6%	+$905K	3.88%	8
2014 Q2	$12.9M	Buy	155,930 +24,480	+19%	+$1.91M	2.78%	11
2014 Q1	$9.31M	Buy	131,450 +14,550	+12%	+$1.14M	2.08%	17
2013 Q4	$8.78M	Buy	116,900 +101,350	+652%	+$7.06M	1.97%	18
2013 Q3	$978K	Sell	15,550 -250	-2%	-$14.9K	0.24%	61
2013 Q2	$810K	Buy	+15,800	New	+$824K	0.21%	64

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jay A. Fishman Ltd's GILD Position: Q1 2016 in Review

Jay A. Fishman Ltd sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 167,645 shares — an estimated $17M sold.

Jay A. Fishman Ltd first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $20.1M in Q2 2015. 1,632 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Jay A. Fishman Ltd reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Jay A. Fishman Ltd sold 167,645 Gilead Sciences shares in Q1 2016, an estimated $17M.
Jay A. Fishman Ltd first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
Jay A. Fishman Ltd's Gilead Sciences position peaked at $20.1M in Q2 2015.
1,632 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Jay A. Fishman Ltd's 13F filing for Q1 2016, filed 10 May 2016.